Source: InnovationNews

Innovus Pharma: Aytu BioScience to acquire Innovus Pharmaceuticals

ENGLEWOOD amp; SAN DIEGO -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, and Innovus

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Bassam Damaj's photo - President & CEO of Innovus Pharma

President & CEO

Bassam Damaj

CEO Approval Rating

90/100

Read more